Abstract

Metastatic breast cancer to the gastrointestinal tract is uncommon with metastasis to the stomach being even more rare, with gastric metastases recognized in only 0.3-18% of patients with Stage 4breast cancer [1]. However it is important to recognize this subtle presentation as diagnosis alters prognosis and treatment approach [2]. Metastasis to the gastrointestinal tract is more commonly seen in ILC compared to IDC, which are biologically and morphologically distinct from each other, with the lack of E-cadherin in ILC postulated as the reason for this phenomenon [3].